NS

Nita Singh

Active Director Director DIN 09727662
DIN 09727662 First appointment Sep 2022 Primary industry Trading
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 2 active board seats
Total affiliations 2 Since Sep 2022
Shareholding value β€’β€’β€’β€’ Premium profile

About Nita Singh

Data last updated:

Nita Singh is a Director at Dr Myles Lab Private Limited (since 2022) and Director at Caresfield Healthcare Private Limited (since 2022). The companies operate in Trading and Chemicals.

DIN 09727662
Primary Designation Director
Industry Trading
First Appointment 06 Sep 2022
Oldest Company Age 4 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Dr Myles Lab Private Limited U51900MH2022PTC394009
Director23 Nov 20222022Active
Director06 Sep 20222022Active

Board colleagues of Nita Singh

Directorship timeline

Open interactive timeline →
Caresfield Healthcare Private Limited
Dr Myles Lab Private Limited
Premium access

Shareholding and investment profile for Nita Singh

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Nita Singh

Nita Singh currently holds 2 directorships: Dr Myles Lab Private Limited (Director, since 23 Nov 2022); Caresfield Healthcare Private Limited (Director, since 06 Sep 2022).

Nita Singh was first appointed on 06 Sep 2022 as Director at Caresfield Healthcare Private Limited.

The current boards of Nita Singh's companies include Priyanka Pandey (Dr Myles Lab Private Limited), Rifat Parveen (Caresfield Healthcare Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available